SG11202105586YA - Modified gip peptide analogues - Google Patents

Modified gip peptide analogues

Info

Publication number
SG11202105586YA
SG11202105586YA SG11202105586YA SG11202105586YA SG11202105586YA SG 11202105586Y A SG11202105586Y A SG 11202105586YA SG 11202105586Y A SG11202105586Y A SG 11202105586YA SG 11202105586Y A SG11202105586Y A SG 11202105586YA SG 11202105586Y A SG11202105586Y A SG 11202105586YA
Authority
SG
Singapore
Prior art keywords
peptide analogues
gip peptide
modified gip
modified
analogues
Prior art date
Application number
SG11202105586YA
Inventor
Alexander Sparre-Ulrich
Bjørn Sivertsen
Ditte Riber
Mette Rosenkilde
Original Assignee
Antag Therapeutics Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antag Therapeutics Aps filed Critical Antag Therapeutics Aps
Publication of SG11202105586YA publication Critical patent/SG11202105586YA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/605Glucagons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/645Secretins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11202105586YA 2018-12-03 2019-12-03 Modified gip peptide analogues SG11202105586YA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18209896 2018-12-03
EP19176739 2019-05-27
PCT/EP2019/083506 WO2020115048A1 (en) 2018-12-03 2019-12-03 Modified gip peptide analogues

Publications (1)

Publication Number Publication Date
SG11202105586YA true SG11202105586YA (en) 2021-06-29

Family

ID=68731999

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202105586YA SG11202105586YA (en) 2018-12-03 2019-12-03 Modified gip peptide analogues

Country Status (12)

Country Link
US (2) US20220025010A1 (en)
EP (2) EP3891174A1 (en)
JP (1) JP2022509568A (en)
KR (1) KR20210102911A (en)
CN (1) CN113366014A (en)
AU (1) AU2019391300A1 (en)
BR (1) BR112021010447A2 (en)
CA (1) CA3121043A1 (en)
IL (1) IL283385A (en)
MX (1) MX2021006505A (en)
SG (1) SG11202105586YA (en)
WO (2) WO2020115049A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022007809A1 (en) * 2020-07-06 2022-01-13 鸿绪生物医药科技(北京)有限公司 Novel polypeptide preparation and therapeutic use thereof
AU2021304762B2 (en) * 2020-07-06 2024-05-02 Vitalixir (Beijing) Co., Ltd Novel polypeptide and therapeutic use thereof
KR20240118914A (en) 2021-01-20 2024-08-05 바이킹 테라퓨틱스 인코포레이티드 Compositions and methods for the treatment of metabolic and liver disorders
BR112023024968A2 (en) * 2021-06-10 2024-02-20 Antag Therapeutics Aps TREATMENT OF OBESITY AND OBESITY-RELATED DISORDERS
WO2023139106A2 (en) 2022-01-18 2023-07-27 Novo Nordisk A/S Long-acting gipr antagonists
CN117402219B (en) * 2022-07-13 2024-07-30 杭州中美华东制药有限公司 GLP-1/GIP double agonist and preparation method and application thereof
CN118255864A (en) * 2022-12-26 2024-06-28 杭州中美华东制药有限公司 GIP receptor agonists and uses thereof
GB202302686D0 (en) * 2023-02-24 2023-04-12 Imperial College Innovations Ltd Novel compounds
WO2024209050A1 (en) * 2023-04-05 2024-10-10 Antag Therapeutics Aps Gip activity modulators and orthostatic intolerance

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869602A (en) 1995-03-17 1999-02-09 Novo Nordisk A/S Peptide derivatives
DE122009000079I2 (en) 1996-08-30 2011-06-16 Novo Nordisk As Novo Alle GLP-1 DERIVATIVES
WO1998024464A1 (en) 1996-12-03 1998-06-11 Trustees Of Boston University Specific antagonists for glucose-dependent insulinotropic polypeptide (gip)
CN1495198A (en) 1998-12-07 2004-05-12 �о���Ӧ�ÿ�ѧЭ��ɷ����޹�˾ Analogs of glucagon-like peptide-1
US20050272652A1 (en) 1999-03-29 2005-12-08 Gault Victor A Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
CZ306180B6 (en) 2000-12-07 2016-09-14 Eli Lilly And Company GLP-1 fusion proteins
WO2004067548A2 (en) 2003-01-31 2004-08-12 Theratechnologies Inc. Chemically modified metabolites of regulatory peptides and methods of producing and using same
AU2006213607A1 (en) * 2005-02-11 2006-08-17 Amylin Pharmaceuticals, Llc GIP analog and hybrid polypeptides with selectable properties
US8263545B2 (en) * 2005-02-11 2012-09-11 Amylin Pharmaceuticals, Inc. GIP analog and hybrid polypeptides with selectable properties
US9023986B2 (en) 2010-10-25 2015-05-05 Hoffmann-La Roche Inc. Glucose-dependent insulinotropic peptide analogs
KR102002783B1 (en) * 2011-06-10 2019-07-24 베이징 한미 파마슈티컬 컴퍼니 리미티드 Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof
KR20150023013A (en) * 2012-06-21 2015-03-04 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 Glucagon analogs exhibiting gip receptor activity
TW201625668A (en) * 2014-04-07 2016-07-16 賽諾菲公司 Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists
TW201625669A (en) * 2014-04-07 2016-07-16 賽諾菲公司 Peptidic dual GLP-1/glucagon receptor agonists derived from Exendin-4
PL3189072T3 (en) * 2014-09-05 2019-04-30 Univ Copenhagen Gip peptide analogues
WO2018117613A1 (en) * 2016-12-19 2018-06-28 한미약품 주식회사 Brain targeting long-acting protein conjugate
CN110691788B (en) * 2017-05-31 2024-05-31 哥本哈根大学 Long acting GIP peptide analogues

Also Published As

Publication number Publication date
AU2019391300A1 (en) 2021-07-01
BR112021010447A2 (en) 2021-08-24
MX2021006505A (en) 2021-10-01
US20220025010A1 (en) 2022-01-27
EP3891173A1 (en) 2021-10-13
US20220298218A1 (en) 2022-09-22
KR20210102911A (en) 2021-08-20
JP2022509568A (en) 2022-01-20
IL283385A (en) 2021-07-29
EP3891174A1 (en) 2021-10-13
WO2020115048A1 (en) 2020-06-11
CA3121043A1 (en) 2020-06-11
CN113366014A (en) 2021-09-07
WO2020115049A1 (en) 2020-06-11

Similar Documents

Publication Publication Date Title
IL283385A (en) Modified gip peptide analogues
IL269581A (en) Gip receptor activating peptide
IL277483A (en) Novel glp-1 analogues
IL283803A (en) Peptide binder
PL3630806T3 (en) Long-acting gip peptide analogues
IL288412A (en) Peptides
PL3189072T3 (en) Gip peptide analogues
IL281224A (en) Peptide vaccines
IL284006A (en) Mitochondria-targeting peptides
EP3906225C0 (en) Pantothenamide analogues
GB201810052D0 (en) Polypeptide
GB201719520D0 (en) Neuroprotectvie peptide
GB201918693D0 (en) Peptide
GB201814440D0 (en) Peptide
GB201912632D0 (en) Peptide
IL290019A (en) Melanocyte-regulating peptides
GB201803074D0 (en) Peptide
GB201807863D0 (en) Peptides
GB201806181D0 (en) Peptides
GB201805809D0 (en) Peptides
GB201805801D0 (en) Peptides
GB201805807D0 (en) Peptides
GB201906982D0 (en) Peptides
GB201902850D0 (en) Antimicroial peptides
GB201806655D0 (en) Polypeptide